• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Stocks

Bearish Bets: 2 Nasdaq Stocks You Should Consider Shorting This Week

These recently downgraded names are displaying both quantitative and technical deterioration.
By BOB LANG
Oct 10, 2021 | 10:30 AM EDT
Stocks quotes in this article: BIIB, ISRG

Each week Trifecta Stocks identifies names that look bearish and may present interesting investing opportunities on the short side.

Using technical analysis of the charts of those stocks, and, when appropriate, recent actions and grades from TheStreet's Quant Ratings, we zero in on five names.

While we will not be weighing in with fundamental analysis, we hope this piece will give investors interested in stocks on the way down a good starting point to do further homework on the names.

Intuitive Surgical

Intuitive Surgical (ISRG)  recently was downgraded to Hold with a C+ rating by TheStreet's Quant Ratings.

Medical device stocks had been hot for a while this year, but there's been a recent moderate correction to Intuitive. Examining things here the volume trends have been strong and bearish and money flow just turned negative. Further, the Relative Strength Index (RSI) shows a steep slope downward and the bearish channel is lengthening. Hence, the trend is still intact.

Moving Average Convergence Divergence (MACD) is on a sell signal.

The 200-day moving average looks like a good target here around $290 or so; put in a stop at $350.

Biogen

Biogen  (BIIB)  recently was downgraded to Hold with a C+ rating by TheStreet's Quant Ratings.

Big biotech name Biogen has been hurting for months. A big surge in June was all she wrote -- the stock has made a steady decline on pretty high turnover. This downtrend does not seem over, though the late May lows might be enough for a pause.

Money flow is very poor, while RSI is flat on its back. This is certainly not a buy for anyone here, but a short still looks attractive. Be patient, but set this to a target of the $225 area and put in a stop at $300.

This commentary is an excerpt from "5 Bearish Bets" a weekly feature sent to subscribers of Trifecta Stocks. Click here to learn more about this portfolio, trading ideas and market commentary product.

Want to find out the other stocks we think look good short this week and how to play them? Click here for a trial subscription to Trifecta Stocks and get "Bearish Bets" each week!

-- Bob Lang and Chris Versace are co-portfolio managers of Trifecta Stocks.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Lang and Trifecta Stocks had no positions in the securities mentioned.

TAGS: Short-selling | Investing | Stocks | Technical Analysis | Trading | Bearish Bet | Quant Ratings | Trifecta Stocks

More from Stocks

All Things Considered, Nike Had a Solid Quarter: Here's the Trade

Stephen Guilfoyle
Jun 28, 2022 10:12 AM EDT

I think the firm is being very conservative in their look forward, carefully and intentionally.

Boston Beer Could Have a Wicked Short-Term Rally in the Weeks Ahead

Bruce Kamich
Jun 28, 2022 8:51 AM EDT

Bottoms up?

AeroVironment Could Resume Its Upward Flight Pattern

Bruce Kamich
Jun 28, 2022 8:13 AM EDT

The drone maker's charts suggest a higher stock price ahead of its latest quarterly earnings report after Tuesday's market close.

The Challenge of Sustained Momentum in an Illiquid Market

James "Rev Shark" DePorre
Jun 28, 2022 7:57 AM EDT

It would be a mistake to assume that the market recovery this time will be swift and easy.

Zero-Covid? NATO's China Challenge, Quarter-End Volume, Yields, Trading Chevron

Stephen Guilfoyle
Jun 28, 2022 7:23 AM EDT

There was a time when Covid vaccine news was headline material. Not now, though, and this news could matter.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 12:04 AM EDT PAUL PRICE

    Two Good Signs -- Especially for Small-Cap Investors

  • 12:10 AM EDT PAUL PRICE

    More Insider Buying in American Woodmark (AMWD)

    American Woodmark , which I've discussed here fr...
  • 08:55 AM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    The 10 personality traits of successful traders an...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login